BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/23/2025 8:06:11 AM | Browse: 239 | Download: 563
 |
Received |
|
2025-02-08 03:32 |
|
Peer-Review Started |
|
2025-02-08 03:33 |
|
First Decision by Editorial Office Director |
|
2025-03-04 11:06 |
|
Return for Revision |
|
2025-03-04 11:06 |
|
Revised |
|
2025-03-09 13:06 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-04-09 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-04-09 07:47 |
|
Articles in Press |
|
2025-04-09 07:47 |
|
Edit the Manuscript by Language Editor |
|
2025-04-16 00:42 |
|
Typeset the Manuscript |
|
2025-05-07 08:25 |
|
Publish the Manuscript Online |
|
2025-05-23 08:06 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Review |
| Article Title |
Liver transplantation for combined hepatocellular-cholangiocarcinoma: Current evidence, selection criteria, and therapeutic controversies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rui-Quan Zhou, Pei-Jun Yang, Tian-Tong Liu, Dong-Dong Han, Xiao-Lei Liu, Li-Guo Liu, Shuang Si, Shi-Wei Yang, Shuai-Shuai Xu, Yi-Wen Guo and Hai-Dong Tan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| High-level Research Projects of China-Japan Friendship Hospital |
2022-NHLHCRF-LX-03-0301, 2023-NHLHCRF-LXYZ-01 |
|
| Corresponding Author |
Hai-Dong Tan, Chief Physician, MD, Second Department of Hepatopancreatobiliary Surgery, China-Japan Friendship Hospital, No. 2 Yinghua Dongjie, Hepingli, Beijing 100029, China. hpblt_cjfh@126.com |
| Key Words |
Combined hepatocellular-cholangiocarcinoma; Liver transplantation; Liver resection; Milan criteria; Lymphadenectomy; Vascular resection; Locoregional therapy; Systemic treatment |
| Core Tip |
Combined hepatocellular cholangiocarcinoma is a rare and aggressive liver malignancy with diagnostic and therapeutic challenges. Although surgical resection remains the primary curative approach, liver transplantation is emerging as a potential option for carefully selected patients, particularly those with early-stage tumors or cirrhosis. Adherence to stringent selection criteria, such as the Milan criteria, is crucial for optimizing post-transplant outcomes. Ongoing research aims to refine the selection framework and improve prognostic accuracy. |
| Publish Date |
2025-05-23 08:06 |
| Citation |
Zhou RQ, Yang PJ, Liu TT, Han DD, Liu XL, Liu LG, Si S, Yang SW, Xu SS, Guo YW, Tan HD. Liver transplantation for combined hepatocellular-cholangiocarcinoma: Current evidence, selection criteria, and therapeutic controversies. World J Gastrointest Surg 2025; 17(5): 105783
|
| URL |
https://www.wjgnet.com/1948-9366/full/v17/i5/105783.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v17.i5.105783 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
